Journal of Chemistry

Volume 2013 (2013), Article ID 183130, 7 pages

http://dx.doi.org/10.1155/2013/183130

Research Article

Synthesis and Microbial Activity of Novel 3-Methyl-2-pyrazolin-5-one Derivatives

Mohamed S. Mostafa,¹ Nasser M. Abd El-Salam,² and Othman Y. Alothman³

¹Chemistry Department, Faculty of Science, Jazan University, P.O. Box 2079, Saudi Arabia

²Riyadh Community College, King Saud University, P.O. Box 28095, Riyadh 11437, Saudi Arabia

³Department of Chemical Engineering, College of Engineering, King Saud University, P.O. Box 800, Riyadh 11421, Saudi Arabia

Received 18 December 2012; Revised 14 March 2013; Accepted 27 March 2013

Academic Editor: Philippe Jeandet

Copyright © 2013 Mohamed S. Mostafa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

2-Oxo-2H-chromene-3-carbohydrazide derivatives 2a,b react with 2-{[4-(substituted thiazol-2-yl)iminoethyl)-phenyl]hydrazono}-3-oxo-butyric acid ethyl esters 4a–c to give 3-methyl-1-[(2-oxo-2H-chromen-3-yl) carbonyl]-4-{[4-(substituted thiazol-2-yl)iminoethyl)-phenyl]hydrazono}]-2-pyrazolin-5-one derivatives 5a–f. A considerable increase in the reaction rate had been observed with better yield using microwave irradiation for the synthesis of compounds 2a, b, 3a–c, and 5a–f. The synthesized products were tested against B. subtilis, S. aureus, and E. coli as well as C. albicans compared with tetracycline and nystatin as reference drugs.

1. Introduction

Pyrazolones are an increasingly popular functionality with wide-range applications. They are used as antibacterial [1], antifungal [2], anti-inflammatory [3], cytotoxic [4], analgesic [5], antiviral [6], and SARS-corona virus 3C-like protease inhibitors [7] agents. Furthermore, 4-(1,3-benzothiazol-2-yl)hydraziny lidene-2,4-dihydro-3H-pyrazol-3-one derivatives have shown good antioxidant activity [8]. On the other hand, the iminothiazoline derivatives have been reported to exhibit antibacterial and antifungal activities [9, 10]. Coumarin derivatives possess various biological activities namely antibacterial [11, 12], antifungal [13], antitumor [14], anticoagulant [15], and anti-inflammatory agents [16]. These compounds are used as additives in food and cosmetics [17], dispersed fluorescent brightening agents, and as dyes for tuning lasers [18]. Microwave irradiation is well known to promote the synthesis of a variety of organic compounds [19–21] where chemical reactions are accelerated because of selective absorption of microwave by polar molecules. In view of these observations we report herein the synthesis of some pyrazolone derivatives, using conventional and microwave irradiated methods, with the hope to get better antimicrobial agents.

2. Experimental

Melting points were estimated using a Stuart apparatus in open capillaries. Purity of compounds was checked by TLC. IR spectra were recorded as KBr pellets on a Jasco FTIR 460 plus spectrophotometer. ¹H-NMR spectra were recorded using a Bruker AV 500 MHz spectrometer using DMSO-d₆ as solvent and TMS as an internal standard. The mass spectral data were obtained with a Micro Spectrometer model 7070 at 70 eV and a 90°C inlet temperature. Elemental analyses were performed on a Perkin-Elmer 240 microanalyser in the Faculty of Science, Cairo University. Microwave irradiations (MWIs) were carried out in a SANYO EM-700T domestic oven (700 W).

3. Synthesis of 2-Oxo-2H-Chromene-3-carbohydrazides (2a,b)

3.1. Method I

A mixture of ethyl-2-oxo-2H-chromene-3-carboxylates (1a,b) (0.01 mole) and hydrazine hydrate 98% (0.5 mole) was refluxed for 2 h. The reaction mixture was poured into water and then the separated solid was filtered off and recrystallized from ethanol to give 2a, b (Tables 1 and 2).

Table 1: Characterization data of synthesized compounds.

Comp
M.P. (°C)
Solvent of crystn.
Yield (%)
Formula (M.W.)
Analysis calcd./found

C
H
N
S

2a
144–146
Ethanol
75

C₁₀H₈N₂O₃
58.82
3.95
13.71
—

(204.185)
58.81
3.97
13.75
—

2b
210–212
Ethanol
60

C₁₀H₇BrN₂O₃
42.43
2.49
9.89
—

(283.081)
42.48
2.46
9.91
—

3a [23]
201–204
Ethanol
62
C₁₁H₁₁N₃S
60.80
5.10
19.33
14.75

(217.29)
60.81
5.13
19.38
14.71

3b
230–232
Ethanol
58

C₁₂H₁₃N₃S
62.85
5.71
18.32
13.98

(229.301)
62.86
5.73
18.37
14.01

3c
271–273
EtOH-H₂O
50

C₁₅H₁₃N₃S
67.38
4.90
15.71
11.99

(267.35)
67.40
4.91
15.69
11.96

4a [23]
165–167
Ethanol
66
C₁₇H₁₈N₄O₃S
56.96
5.06
15.63
8.94

(358.416)
56.98
5.04
15.67
8.98

4b
186–188
Ethanol
62

C₁₈H₂₀N₄O₃S
58.04
5.41
15.04
8.60

(372.443)
58.09
5.40
15.07
8.66

4c
140–142
Ethanol
60

C₂₁H₂₀N₄O₃S
61.74
4.93
13.71
7.84

(408.476)
61.78
4.96
13.69
7.88

5a
208–210
Ethanol
60

C₂₅H₁₈N₆O₄S
60.23
3.63
16.85
6.43

(498.517)
60.20
3.66
16.80
6.47

5b
232–234
Ethanol
54

C₂₆H₂₀N₆O₄S
60.92
3.93
16.39
6.25

(512.544)
60.94
3.98
16.42
6.30

5c
222–224
DMF
57

C₂₉H₂₀N₆O₄S
63.49
3.67
15.32
5.84

(548.577)
63.51
3.62
15.38
5.88

5d
280–282
DMF
50

C₂₅H₁₇BrN₆O₄S
52.00
2.96
14.55
5.55

(577.413)
52.08
3.99
14.51
5.59

5e
250–252
DMF
48

C₂₆H₁₉BrN₆O₄S
52.80
3.23
14.20
5.42

(591.44)
52.78
3.20
14.28
5.45

5f
264–267
Pet-ether
37
C₂₉H₁₉BrN₆O₄S
55.51
3.05
13.39
5.10

(627.473)
55.50
3.03
13.41
5.12

Table 2: Comparison of conventional and microwave synthesis.

Compd.
Conventional
Microwave

% yield
/hrs
% yield
/min

2a
75
2
94
3

2b
60
2
98
3

3a
64
4
82
3

3b
58
4
86
3.5

3c
50
4
89
2

5a
60

8
93
3

5b
54

8
88
3

5c
57

8
82
3

5d
50

9
91
3

5e
48

8
83
3

5f
37
8
81
4

3.2. Method II

Hydrazine hydrate (0.01 mole), 1a,b (0.01 mole), and absolute ethanol (2 mL) were irradiated in an Erlenmeyer flask under MWI for 3 min. The reaction mixture was cooled, and the separated solid was filtered off and washed with water to yield 2a,b (Table 3).

Table 3: Spectral data of synthesized compounds.

Comp.
IR cm⁻¹
1H-NMR δ ppm
MS

2a
3304–3245 (NH₂), 3078 (NH), 1730 (lactone C=O) and 1682 cm⁻¹ (amidic CO).
7.01–7.48 (m, 3H, ArH), 9.36 (s, 1H, CH-4), 11.14 (s, 1H, NH) and 12.01 (s, 2H, NH₂).
M⁺: 204 (100%)

2b
3311–3239 (NH₂), 3046 (NH), 1721 (lactone C=O) and 1680 cm⁻¹ (amidic CO)
7.12–7.54 (m, 3H, ArH), 9.41 (s, 1H, CH-4), 11.21 (s, 1H, NH) and 12.11 (s, 2H, NH₂).
M+1: 284 (32.67%), M⁺: 283 (61.06%)

3b
3400–3312 (NH₂), 1640 (C=N)
2.01 (s, 3H, CH₃), 2.72 (s, 3H, CH₃), 6.88 (s, 2H, NH₂, D₂O-exchangeable, 7.22–7.82 (m, 5H, ArH).
M⁺: 229 (100%), 97 (55.98%).

3c
3400–3312 (NH₂), 1640 (C=N)
2.78 (s, 3H, CH₃), 6.10 (s, 2H, NH₂, D₂O-exchangeable, 7.35–7.68 (m, 8H, ArH).
M⁺: 267 (46.11%), 133 (100%).

4b
1760 (C=O), 1630 (C=N), 1560 (N=N).

0.91 (s, 3H, CH₃), 1.21 (t, 3H, OCH₂CH₃), 2.60 (s, 3H, CH₃), 2.88 (s, 3H, CH₃), 3.0 (s, 1H, CH), 4.20–4.22 (q, 2H, OCH₂CH₃), 6.70–7.60 (m, 5H, ArH).
M⁺: 372 (88.34%), 328 (22.56%), 254 (43.87%), 156 (52%).

4c
1755 (C=O), 1622 (C=N), 1560 (N=N).
1.27 (t, 3H, OCH₂CH₃), 2.57 (s, 3H, CH₃), 2.80 (s, 3H, CH₃), 3.22 (s, 1H, CH), 4.27–4.29 (q, 2H, OCH₂CH₃), 6.66–7.98 (m, 8H, ArH).
M⁺: 408 (22.11%), 364 (56.54%), 290 (78.23%), 156 (23.11%).

5a
3202 (NH), 1710 (lactone CO), 1677 (CO), 1586 (C=N).
2.03 (s, 3H, CH₃), 2.92 (s, 3H, CH₃), 4.58 (s, 1H, CH), 7.31–7.52 (m, 10H, ArH), 9.72 (s, 1H, CH-4), 11.40 (s, 1H, NH, disappeared after D₂O exchange)
M⁺: 498 (23.11%), 267 (52.34%), 229 (26.87%), 121 (7.08%), 92 (17.58%), 84 (39.76%).

5b
3106 (NH), 1719 (lactone CO), 1680 (CO), 1582 (C=N).
1.44 (s, 3H, CH₃), 2.03 (s, 3H, CH₃), 2.88 (s, 3H, CH₃), 4.61 (s, 1H, CH), 7.31–7.52 (m, 9H, ArH), 9.66 (s, 1H, CH-4), 11.07 (s, 1H, NH, disappeared after D₂O exchange)
M⁺: 512 (42.26%), 267 (65%), 242 (36.98%), 121 (19.78%), 97 (14.44%), 92 (22.32%)

5c
3135 (NH), 1713 (lactone CO), 1654 (CO), 1567 (C=N).
2.45 (s, 3H, CH₃), 2.99 (s, 3H, CH₃), 4.28 (s, 1H, CH), 6.78–8.89 (m, 12H, ArH), 9.21 (s, 1H, CH-4), 11.11 (s, 1H, NH, disappeared after D₂O exchange)
M⁺: 548 (100%), 279 (15.47%), 267 (25.96%), 133 (44.11%), 121 (45.34%), 92 (13.67%).

5d
3065 (NH), 1722 (lactone CO), 1682 (CO), 1560 (C=N).
2.19 (s, 3H, CH₃), 2.86 (s, 3H, CH₃), 4.65 (s, 1H, CH), 7.11–7.95 (m, 9H, ArH), 9.70 (s, 1H, CH-4), 11.32 (s, 1H, NH, disappeared after D₂O exchange)
M+1: 578 (22.52%), M⁺: 577 (78.93%), 344 (32.33%), 229 (21.45%), 84 (76.23%).

5e
3116 (NH), 1709 (lactone CO), 1673 (CO), 1551 (C=N).
1.31 (s, 1H, CH₃), 2.73 (s, 3H, CH₃), 2.99 (s, 3H, CH₃), 4.95 (s, 1H, CH), 7.11–7.54 (m, 8H, ArH), 9.72 (s, 1H, CH-4), 11.98 (s, 1H, NH, disappeared after D₂O exchange)
M+1: 520 (98%), M⁺: 519 (38%), 344 (16.95%), 242 (68.23%), 121 (19%), 97 (23.31%).

5f
3109 (NH), 1725 (lactone CO), 1686 (CO), 1509 (C=N).
2.19 (s, 3H, CH₃), 2.86 (s, 3H, CH₃), 4.65 (s, 1H, CH), 6.91–8.12 (m, 11H, ArH), 9.04 (s, 1H, CH-4), 10.56 (s, 1H, NH, disappeared after D₂O exchange)
M+1: 628 (15.12%), M⁺: 627 (34%), 344 (71.71%), 279 (51.11%), 133 (55.04%).

4. Synthesis of 1-(4-Aminophenyl)-1-(substituted thiazol-2-yl)iminoethanes 3a–c

4.1. Method I

A mixture of 4-aminoacetophenone (0.01 mole) and the appropriate amine, namely, (2-aminothiazole, 2-amino-5-methylthiazol and 2-aminobenzothiazole) (0.01 mole for each) in DMF (30 mL) was heated under reflux for 4 h. The precipitated solid formed after cooling was collected by filtration. Then, it was washed with water, dried, and crystallized to afford 3a–c (Tables 1 and 2).

4.2. Method II

A solution of 4-aminoacetophenone (0.01 mole) in methanol (30 mL) and 2-aminothiazoles (0.01 mole) was put in round-bottomed flask placed in a microwave oven and irradiated for 2.0–3.5 min, and then the solvent was removed by vacuum distillation. The solid product was filtered, dried, and recrystallized from ethanol to give 3a–c (Table 3).

5. Synthesis of 2-{[4-(Substituted thiazol-2-yl)iminoethyl)-phenyl]Hydrazono}-3-oxo-Butyric Acid Ethyl Ester 4a–c

A solution of sodium nitrite (0.01 mole) in water (10 mL) was added to an ice-cooled mixture of 3a–c (0.01 mole) in concentrated HCl (10 mL) and water (10 mL). The diazotized compound was dropped while cooling with stirring over a cold mixture of ethyl acetoacetate (0.01 mole) and sodium acetate (2 g in 10 mL water) in ethanol (20 mL). The reaction mixture was stirred at room temperature for 8 h. The precipitated solid was collected by filtration. Then it was washed with water, dried, and recrystallized to afford 4a–c (Tables 1 and 2).

6. Synthesis of 3-Methyl-1-[(2-oxo-2H-chromen-3-yl) carbonyl]-4-{[4-(substituted thiazol-2-yl)iminoethyl)-phenyl]hydrazono}]-2-pyrazolin-5-one Derivatives (5a–f)

6.1. Method I

A mixture of 4a–c (0.002 mole for each) and (2a,b) (0.002 mole for each) in acetic acid (15 mL) was refluxed for 8 h. The reaction mixture was then allowed to stand overnight. After conclusion of the reaction (TLC), the reaction mixture was poured onto crushed ice to give sticky product which was extracted from ether for three times. The organic layer was washed with water. Then, it was dried with MgSO₄ and filtered. After that, the solvent was removed under vacuum to give 5a–f (Tables 1 and 2).

6.2. Method II

A mixture of 4a–c (0.01 mole for each), 2a,b (0.01 mole for each), and glacial acetic acid (2 mL) in an Erlenmeyer flask was exposed to pulsed microwave irradiation using microwave oven for 3 min. The reaction mixture was poured onto crushed ice; the separated solid was filtered, then washed with water, and dried to give the pyrazolin-5-ones 5a–f (Table 3).

7. Results and Discussion

Treatment of ethyl-2-oxo-2H-chromene-3-carboxylates (1a,b) [22] with hydrazine hydrate under heating reflux afforded 2-oxo-2H-chromene-3-carbohydrazide derivatives 2a,b. Again, compounds 2a,b were obtained in a 94–98% yield by irradiation of (1a,b) with hydrazine hydrate in ethanol under MWI for 3 min (Figure 1).

Figure 1

The IR (KBr) of compounds 2a,b displayed absorption bands at 3321(NH₂), 3078(NH), 1730(lactone C=O), and 1682 cm⁻¹ for amidic CO. The structure of 2b was also confirmed by its mass spectrum that shows molecular ion peaks (M⁺) at m/z 283(61.06%, ⁷⁹Br) and m/z 284(32.67%, ⁸¹Br).

It has been found that the 4-aminoacetophenone reacted with 2-amino-5-methylthiazole or 2-aminobenzothiazole in DMF to give the imino derivatives (3b,c), similar to compound (3a) [23]. It was found that the higher yields of compounds 3a–c were obtained at 500 watt for 2-3 min of microwave irradiation (Figure 2).

Figure 2

IR spectrum (KBr) of 3b, as an example, showed bands at 3400-3388 (NH₂), and 1640 cm⁻¹ for C=N. The ¹H-NMR spectrum (DMSO-d₆) of 3b showed signals at δ 2.01 (s. 3H, CH₃), 2.72 (s. 3H, CH₃), 6.88 (s, 2H, NH₂, D₂O-exchangeable), and 7.22–7.82 ppm (m, 5H, ArH). Diazotization of 3a–c followed by coupling with ethyl acetoacetate in presence of sodium acetate gave 2-{[4-(substituted thiazol-2-yl)iminoethyl)-phenyl]hydrazono}-3-oxo-butyric acid ethyl esters 4a–c (Figure 3).

Figure 3

IR spectra of 4a–c revealed no absorption band in amino group region; furthermore, it displayed absorption bands at 1760 and 1560 cm⁻¹ for ester group and (N=N), respectively. The ¹H-NMR spectrum (DMSO-d₆) of compound 4c, as an example, exhibited signals at δ 1.27 (t, 3H, OCH₂CH₃), 2.57 (s, 3H, CH₃), 2.80 (s, 3H, CH₃), 3.22 (s, 1H, CH), 4.27–4.29 (q, 2H, OCH₂CH₃) and 6.66–7.98 ppm (m, 8H, ArH).

Refluxing compounds 2a,b and 4a–c in acetic acid for 8 hrs lead to 3-methyl-1-[(2-oxo-2H-chromen-3-yl) carbonyl]-4-{[4-(substituted thiazol-2-yl)iminoethyl)-phenyl]hydrazono}]-2-pyrazolin-5-one derivatives 5a–f. These pyrazolin-5-one derivatives were obtained in good yield through the irradiation of a mixture of 2a,b and 4a–c using microwave oven for 3-4 min (Figure 4).

Figure 4

The ¹H-NMR spectrum (DMSO-d₆) of compounds 5a, as an example, showed signals at δ 2.03 (s, 3H, CH₃), 2.92 (s, 3H, CH₃), 4.58 (s, 1H, CH), 7.31–7.52 (m, 10H, ArH), 9.72 (s, 1H, CH-4), and 11.40 ppm (s, 1H, NH, disappeared after D₂O exchange). The infrared spectrum of compounds 5a–f revealed absorption bands characteristic for NH, lactone CO, CO, and C=N. The mass spectra of compounds containing bromine atoms (5d,5e, and 5f) showed fragments corresponding to the typical bromine isotope (⁷⁹Br and ⁸¹Br) patterns. Thus, the mass spectrum of 5d shows its M+1 and M⁺ peaks at m/z 578 (22.52%) and 577 (78.93%), respectively (Table 3).

8. Antimicrobial Activity

The antimicrobial activity of new compounds was investigated against a variety of microorganisms, including the gram-positive bacteria Bacillus subtilis and Staphylococcus aureus and the gram-negative bacteria Escherichia coli as well as the unicellular fungi Candida albicans. The agar plate disc-diffusion method [24] was used to assess the activity of the compounds. Sterilized filter paper discs (5 mm in diameter) were wetted with 10 μL each of a solution of the tested compound (10 mg/mL of the compound in DMF). The discs were then allowed to dry and were placed on the surface of agar plates seeded with the test organism. Nutrient agar was used for bacterial plating and sabourauds dextrose agar for fungi. Each plate contained 15 mL of the agar medium, previously seeded with 0.2 mL of an 18 h-old broth culture of each organism. The inoculated plates were incubated at 37°C for 48 h with the test discs in place, and the inhibition zones were measured in mm. Controls including the use of the solvent DMF without test compounds that showed no antimicrobial activity for this solvent. The antibacterial reference tetracycline discs and the antifungal reference nystatin discs were tested concurrently as standards.

Concerning the data of antimicrobial activity in Table 4, some of the synthesized compounds showed antibacterial activity comparable to that of tetracycline (the reference drug used). Concerning the activity against gram-positive bacteria (Bacillus subtilis), 3-methyl-1-[(2-oxo-2H-chromen-3-yl)carbonyl]-4-[(4-thiazol-2-yl)iminoethyl)phenyl) hydrazon]-2-pyrazolin-5-one derivative (5a) showed excellent activity, and compounds 5b and 5d exhibited good activity, whereas compounds 4c,5e, and 5f showed moderate activity. All synthesized compounds exhibited moderate activity against Staphylococcus aureus. Compounds 5a and 5f showed excellent activity against gram-negative bacteria Escherichia coli. On the other hand, the unicellular fungi Candida albicans showed high responses to 5d.

Table 4: Antimicrobial activity of prepared compounds.

Compd. no.
Inhibition zones (mm)

Gram +ve bacteria
Gram −ve bacteria
Fungi

B. subtilis
S. aureus
E. coli
C. albicans

2a
18
14
12
19

2b
13
10
11
20

3b
16
14
10
13

3c
14
12
15
11

4b
17
18
18
22

4c
22
17
16
20

5a
29
10
21
19

5b
23
10
11
18

5c
19
15
20
10

5d
23
10
19
25

5e
22
14
13
15

5f
20
18
22
13

Tetracycline
28
26
20
—

Nystatin
—
—
—
24

9. Conclusion

This paper describes the synthesis, spectral characterization, and screening of antimicrobial activity of some 3-methylpyrazolin-5-one derivatives bearing side chains, imino-thiazole-phenylhydrazone derivatives, and coumarin moiety. Microwave-assisted synthesis was also used to improve the yield and reaction time. The synthesized compounds showed a wide range of potentially promising antimicrobial activities.

Acknowledgment

The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding the work through the research group project no. RGP-VPP-133.

References

P. T. Pavlov, A. F. Goleneva, A. E. Lesnov, and T. S. Prokhorova, “Biological activity of some pyrazolone derivatives,” Pharmaceutical Chemistry Journal, vol. 32, no. 7, pp. 370–372, 1998.

D. Singh and D. Singh, “Synthesis and antifungal activity of some 4-arylmethylene derivatives of substituted pyrazolones,” Journal of the Indian Chemical Society, vol. 68, no. 3, pp. 165–167, 1991.

G. Mariappan, B. P. Saha, L. Sutharson, and A. Haldar, “Synthesis and bioactivity evaluation of pyrazolone derivatives,” Indian Journal of Chemistry B, vol. 49, no. 12, pp. 1671–1674, 2010.

H. P. Devnath and R. Islam, “Synthesis of some pyrazolone derivatives from ciprofloxacin and study of their cytotoxicity,” Bangladesh Journal of Pharmacology, vol. 5, no. 1, pp. 30–34, 2010.

M. Amir and S. Kumar, “Synthesis and anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation activities of 3,5-dimethyl pyrazoles, 3-methyl pyrazol-5-ones and 3,5-disubstituted pyrazolines,” Indian Journal of Chemistry B, vol. 44, no. 12, pp. 2532–2537, 2005.

A. N. Evstropov, V. E. Yavorovskaya, E. S. Vorob'ev et al., “Synthesis and antiviral activity of antipyrine derivatives,” Pharmaceutical Chemistry Journal, vol. 26, no. 5, pp. 426–430, 1992.

R. Ramajayam, K. P. Tan, H. G. Liu, and P. H. Liang, “Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors,” Bioorganic and Medicinal Chemistry, vol. 18, no. 22, pp. 7849–7854, 2010.

K. Siva and A. Rajasekharan, “Synthesis and Characterisation, in vitro antioxidants activity of N-mannich base of pyrazolone derivatives,” International Journal of Research of Pharmacy and Chemistry, vol. 2, no. 2, pp. 327–337, 2012.

A. Gürsoy and N. Karali, “Synthesis, characterization and primary antituberculosis activity evaluation of 4-(3-Coumarinyl)-3-benzyl-4-thiazolin-2-one benzylidenehydrazones,” Turkish Journal of Chemistry, vol. 27, no. 5, pp. 545–551, 2003.

S. Hiremath, K. Swamy, and B. Mruthyunjayaswamy, “Synthesis and antimicrobial activity of 4-amino-3-(2’-phenyindol-3’-yl)-2-imino-4-thiozoline-5-carbonitrilies and their derivatives,” Journal of the Indian Chemical Society, vol. 69, p. 87, 1992.

O. A. Abd Allah, “Synthesis and biological studies of some benzopyrano[2,3-c]pyrazole derivatives,” Farmaco, vol. 55, no. 9-10, pp. 641–649, 2000.

A. M. El-Agrody, M. S. Abd El-Latif, N. A. El-Hady, A. H. Fakery, and A. H. Bedair, “Heteroaromatization with 4-Hydroxycoumarin Part II: synthesis of some new pyrano[2,3-d]pyrimidines, [1,2,4]triazolo[1,5-c]pyrimidines and pyrimido[1,6-b]-[1,2,4]triazine derivatives,” Molecules, vol. 6, no. 6, pp. 519–527, 2001.

M. A. Al-Haiza, M. S. Mostafa, and M. Y. El-Kady, “Synthesis and biological evaluation of some new coumarin derivatives,” Molecules, vol. 8, no. 2, pp. 275–286, 2003.

F. Belluti, G. Fontana, L. D. Bo, N. Carenini, C. Giommarelli, and F. Zunino, “Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: identification of novel proapoptotic agents,” Bioorganic and Medicinal Chemistry, vol. 18, no. 10, pp. 3543–3550, 2010.

H. El-Diwani and H. El-Sahrawi, “Synthesis and anticoagulant, antipyretic and analgesic activities of some 4H-1benzopyran-4-one derivatives,” Indian Journal of Chemistry B, vol. 34, pp. 27–31, 1995.

K. N. Venugopala and B. S. Jayashree, “Synthesis of carboxamides of 2-amino-4-(6-bromo-3-coumarinyl) thiazole as analgesic and antiinflammatory agents,” Indian Journal of Heterocyclic Chemistry, vol. 12, no. 4, pp. 307–310, 2003.

R. O'Kennedy and R. Thornes, Coumarins: Biology, Applications and Mode of Action, John Wiley & Sons, Chichester, UK, 1997.

M. Zahradnik, The Production and Application of Fluorescent Brightening Agent, John Wiley & Sons, Chichester, UK, 1992.

P. Gothwal, G. Malhotra, and Y. K. Srivastava, “Microwave Assisted Synthesis and antimicrobial activities of some 3-[4'-(4“-nitrophenoxy)-phenyl] -5-(substituted aryl)-2-pyrazoline-1- thiocarboamides,” International Journal of Green and Herbal Chemistry, vol. 1, no. 1, pp. 39–45, 2012.

B. Parashar, S. Bhardwaj, S. Sharma, G. Gupta, V. Sharma, and P. Punjabi, “Comparative conventional and microwave assisted synthesis of some pyrazoline derivatives and their antimicrobial activity,” Journal of Chemical and Pharmaceutical Research, vol. 2, no. 3, pp. 33–42, 2010.

M. Srinivas, A. Tejasri, N. Anjaneyulu, and K. Satyanarayana, “Microwave assisted synthesis and antimicrobial activity of some novel quinoxaline compounds,” International Journal of Pharma Sciences, vol. 3, no. 1, pp. 142–146, 2013.

K. Suresh, M. Veeresh, A. Prashant et al., “Synthesis and pharmacological evaluation of a novel series of 5-(substituted)aryl-3-(3-coumarinyl)-1-phenyl-2-pyrazolines as novel anti-inflammatory and analgesic agents,” European Journal of Medicinal Chemistry, vol. 30, pp. 1–7, 2008.

F. E. Goda, A. R. Maarouf, and E. R. EL-Bendary, “Synthesis and antimicrobial evaluation of new isoxazole and pyrazole derivatives,” Saudi Pharmaceutical Journal, vol. 11, no. 3, pp. 111–117, 2003.

C. H. Collins and P. M. Lyne, Microbiological Methods, Butterworths, London, UK, 4th edition, 1976.